|
|
Article: ASCEND Therapeutics Files Patent Applications for Drug Planned to Treat Benign Breast Disease; Patents Expand Intellectual Property of ASCEND's Unique Gel-Based Approach to the Treatment of Benign Breast Disease.
- Article from:
- PR Newswire
- Article date:
- August 12, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HERNDON, Va., Aug. 12 /PRNewswire/ -- ASCEND Therapeutics today announced that it has filed a patent application for both the pharmaceutical composition of TamoGel(TM) (4-hydroxytamoxifen gel) and the gel's use for the treatment of benign breast disease.
The patents provide protection for ASCEND's transdermal approach to the treatment of chronic conditions like benign breast disease, and solidify the company's proprietary technology position within the breast health therapy market.
Each year approximately 3 million women will experience a first incidence of benign breast disease. The term benign breast disease encompasses a number of nonproliferative ...